A drug about to be rejected works in some bladder cancers Researchers from the IMIM proposed a trial, with promising results. La Vanguardia
This website uses cookies to improve the browsing experience and perform analytical tasks. If you continue browsing, we understand that you agree our cookies policy. More information
